BCM
AGN

Beck Capital Management’s Allergan Inc AGN Stock Holding History

Beck Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,485
Closed -$405K – 161
2015
Q3 		$405K Buy
+1,485
New +$405K 0.28% 67

Other funds holding AGN

SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return
AWM
Altavista Wealth Management Asheville, North Carolina $496M AUM 20.88% 1-Year Est. Return
III
Independent Investors Inc Nesconset, New York $524M AUM 29.67% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
ODCM
Old Dominion Capital Management Charlottesville, Virginia $467M AUM 25.94% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
HHAA
Henry H. Armstrong Associates Pittsburgh, Pennsylvania $1.03B AUM 4.23% 1-Year Est. Return
AGA
Accuvest Global Advisors Provo, Utah $107M AUM 6.41% 1-Year Est. Return
LCM
Liberty Capital Management Birmingham, Michigan $582M AUM

Beck Capital Management's AGN Position: Q4 2015 in Review

Beck Capital Management sold out of Allergan Inc (AGN) in Q4 2015, closing a stake of 1,485 shares — an estimated $405K sold.

Beck Capital Management first reported a position in AGN in Q3 2015 and held it in 1 quarter. The position peaked at $405K in Q3 2015. 28 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Beck Capital Management reported no remaining Allergan Inc position as of Q4 2015 after selling out during the quarter.
  • Beck Capital Management sold 1,485 Allergan Inc shares in Q4 2015, an estimated $405K.
  • Beck Capital Management first reported a position in Allergan Inc in Q3 2015 and held it in 1 quarter.
  • Beck Capital Management's Allergan Inc position peaked at $405K in Q3 2015.
  • 28 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2015.

Based on Beck Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.